Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,725 Jan 1 – Oct 25, 2026
- Disclosed funding
- $346.1B 3681 disclosed amounts
- Median round
- $14.7M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| C Provides AI platform for enterprise travel and expense management | $11.5M | Series A | AI | United States | Investors | |
| Q Develops control systems for quantum computing experiments | €162K | Undisclosed | Hardware | Switzerland | Investors | |
| vH vVARDIS HoldingCompany profile Develops non-invasive peptide-containing formulations to treat tooth decay Develops non-invasive peptide-containing formulations to treat tooth decay | Undisclosed | StrategicUndisclosed | Healthtech | Switzerland | Investors | |
| X X-energyCompany profile X-energy develops small modular nuclear reactors and TRISO fuel for electricity and industrial energy. X-energy develops small modular nuclear reactors and TRISO fuel for electricity and industrial energy. | ~$1.1B | IPO (net proceeds)Undisclosed | Climate tech | United States | Investors Undisclosed | |
| P Develops intracoronary liquid biopsy for cardiovascular disease | $5M | Undisclosed | Biotech | United Kingdom | Investors Undisclosed | |
| S Provider of physical AI for warehouse robotics | $110M | Series B | Robotics | Germany | Investors | |
Four PillarsCompany profile Blockchain research, institutional advisory and validator infrastructure connecting Asian and global markets. Blockchain research, institutional advisory and validator infrastructure connecting Asian and global markets. | Undisclosed | Series A | Fintech | South Korea | Investors | |
| FT Uses quantum chemistry and AI to design novel drug molecules | $47M | Series A | Biotech | United States | Investors | |
| N NervonikCompany profile Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions | $52.5M | Series B | Healthtech | United States | Investors | |
| II Building an AI system that learns autonomously | $1.1B | Seed | AI | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
112rounds22led - 3General Catalyst
Tractian, Legora, Different
100rounds12led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Warhound, Whop, Blacksmith
71rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →